Design of Multi-Cancer VOCs Profiling Platform via a Deep Learning-Assisted Sensing Library Screening Strategy.

Journal: Analytical chemistry
PMID:

Abstract

The efficiency of sensor arrays in parallel discrimination of multianalytes is fundamentally influenced by the quantity and performance of the sensor elements. The advent of combinational design has notably accelerated the generation of chemical libraries, offering numerous candidates for the development of robust sensor arrays. However, screening elements with superior cross-responsiveness remains challenging, impeding the development of high-performance sensor arrays. Herein, we propose a new deep learning-assisted, two-step screening strategy to identify the optimal combination of minimal sensor elements, using a designed volatile organic compounds (VOCs)-targeted sensor library. 400 sensing elements constructed by pairing 20 ionizable cationic elements and 20 anionic dyes in the sensor library were employed for various VOCs, generating plentiful color variation data. By employing a feedforward neural network─random forest-recursive feature elimination (FRR) algorithm, sensing elements were effectively screened, resulting in the rapidly producing 8-element and 10-element arrays for two VOC models, both achieving 100% discrimination accuracy. Furthermore, a smartphone-based point-of-care testing (POCT) platform achieved cancer discrimination in a simulated cancer VOC model, using image-based deep learning, demonstrating the rationality and practicality of deep learning in the assembly of sensor elements for parallel sensing platforms.

Authors

  • Xu Gao
    National Research Base of Intelligent Manufacturing Service, School of Management Science and Engineering, Chongqing Technology and Business University, Chongqing, 400067, China; Chongqing Water Group Co. Ltd., Chongqing, 400042, China. Electronic address: hughgao@outlook.com.
  • Shuoyang Ma
    State Key Laboratory of Natural Medicines, National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 211198, China.
  • Weiwei Ni
    State Key Laboratory of Natural Medicines, National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 210009, China.
  • Yongbin Kuang
    State Key Laboratory of Natural Medicines, National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 210009, China.
  • Yang Yu
    Division of Cardiology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lingjia Zhou
    State Key Laboratory of Natural Medicines, National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 211198, China.
  • Yong Li
    Department of Surgical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States.
  • Chao Guo
    Department of Cardiology, Fuwai Hospital CAMS and PUMC, Beijing 100037, China.
  • Chao Xu
    Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China;Department of Emergency, Zhejiang Hospital, Hangzhou 310013, China.
  • Linxian Li
    Department of Neuroscience, Karolinska Institutet, Stockholm 17177, Sweden.
  • Hui Huang
    Department of Biobank, The Sixth Affiliated People's Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Jinsong Han
    State Key Laboratory of Natural Medicines and National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 211109, China.